Clinical Trial Update: Evaluating the Effect of N-Acetyl Cysteine and Alpha Lipoic Acid in Patients With Beta Thalassemia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the combination of N-Acetyl Cysteine and Alpha Lipoic Acid in Beta-thalassemia is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia

Drugs mentioned

• Alpha Lipoic Acid (alpha-lipoic acid)
• N-Acetyl-Cysteine (N-acetylcysteine)

Snippet

Sponsor: Tanta University | Conditions: Beta Thalassemia | Phase 3 | Status: NOT_YET_RECRUITING